|
|
| IPO Open | Sep 25, 2007 |
| IPO Close | Sep 28, 2007 |
| IPO Price | ₹10 |
| Face Value | ₹10 |
| IPO Size | ₹15.00 Cr |
| Listing At | BSE |
| Lot Size | 500 |
Oct 27, 2022 4:30:00 AM
Last week, gene editing startup Prime Medicine announced it will brave the unforgiving public market with a $175 million IPO. The company followed Third Harmonic’s $180 million August debut, making ...
Publish by : news.crunchbaseNov 11, 2022 3:30:00 AM
Three biotech companies are going public this week and NanoString looks better than Prosensa or Esperion says Francis Gaskins. Disclosure: TheStreet's editorial policy prohibits staff editors ...
Publish by : TheStreet.comAug 1, 2009 4:30:00 PM
After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...
Publish by : NatureOct 22, 2022 4:41:00 AM
Initial public offerings are the lifeblood of the biotech industry. Stock listings give young companies access to the vast amount of cash necessary to advance their drugs through clinical development, ...
Publish by : BioPharma DiveMay 19, 2020 8:34:00 PM
Legend Biotech is spinning out from parent firm GenScript Biotech to pursue treatments in CAR T cell therapies for multiple myeloma. Legend Biotech is spinning out from parent firm GenScript ...
Publish by : TheStreet.comNov 4, 2022 4:30:00 AM
If you break New York and New Jersey into distinctly different clusters, then Boston is the undisputed champion of biotech IPO activity. New York by itself has only produced two biotech IPOs this ...
Publish by : XconomyNov 11, 2022 1:55:00 PM
The IPO page of Cauvery Biotech Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's Open Price, High ...
Publish by : IndiatimesNov 23, 2022 7:20:00 AM
The IPO page of Emmessar Biotech & Nutrition Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's Open ...
Publish by : IndiatimesOct 24, 2022 4:30:00 AM
As Xconomy colleague Luke Timmerman reported in August, “the biotech IPO class of 2012 has made money for investors, while tech’s most glamorous up-and-comers have been stumbling…By my count ...
Publish by : XconomyIPO Allotment Status is now available online for Saamya Biotech India Limited.
Saamya Biotech India Limited IPO was closed on September 28, 2007.
Saamya Biotech India Limited IPO listing info:
IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share
Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.
SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).
The Saamya Biotech IPO is proposed to open on Sep 25, 2007. The IPO application ends on Sep 28, 2007.
Retail investors can apply in the retail or non-institutional investor category from Sep 25, 2007 to Sep 28, 2007. The Saamya Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Saamya Biotech IPO will open for subscription on Sep 25, 2007. The public issue will close on Sep 28, 2007.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
